Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

  • This share is currently suspended. It was suspended at a price of 164.40
  • There is currently no data for APAX

Form 8.5 (EPT/RI)

2 Sep 2025 11:30

RNS Number : 6506X
Winterflood Securities Limited
02 September 2025
 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Winterflood Securities Ltd

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

APAX Global Alpha Ltd

(c) Name of the party to the offer with which exempt principal trader is connected:

APAX Global Alpha Ltd

(d) Date dealing undertaken:

01/09/2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

APAX Global Alpha Ltd

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

Ordinary shares

Purchases

2,258

1.63 GBP

1.63 GBP

Ordinary shares

Sales

1

1.63 GBP

1.63 GBP

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

NIL

NIL

NIL

NIL

NIL

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

NIL

NIL

NIL

NIL

NIL

NIL

NIL

NIL

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

NIL

NIL

NIL

NIL

NIL

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

NIL

NIL

 

NIL

NIL

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

None

 

 

 

Date of disclosure:

02/09/2025

Contact name:

Alex Giacopazzi

Telephone number:

020 3100 0427

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERGZGGLLZMGKZG
Date   Source Headline
19th Aug 20217:00 amRNS2021 Interim Dividend
19th Aug 20217:00 amRNS2021 Interim Report and Accounts
19th Aug 20217:00 amRNS2021 Interim Results Highlights
5th Aug 20217:00 amRNSApax Funds’ Valuations as at 30 June 2021
4th Aug 20217:00 amRNSApax Funds create social good software platform
22nd Jul 20217:00 amRNSInitial Public Offering of Paycor
14th Jul 20217:00 amRNSFunds advised by Apax announce investment in Tide
6th Jul 20217:00 amRNSIPO of Baltic Classifieds Group
24th Jun 20217:00 amRNSApax Funds announce investment in Revolution Prep
16th Jun 20217:00 amRNSApax Funds invest in CyberGrants
14th Jun 20217:00 amRNSFunds advised by Apax to acquire Infogain
27th May 20217:00 amRNSProposed commitment to Apax Digital Fund II
25th May 20217:00 amRNSFunds advised by Apax invest in Faculty
20th May 20217:00 amRNSResult of secondary placing in Apax Global Alpha
19th May 20214:35 pmRNSSecondary placing of shares in Apax Global Alpha
14th May 20217:00 amRNSInitial Public Offering of Global-e
14th May 20217:00 amRNSFunds advised by Apax to acquire Nulo
5th May 20217:00 amRNSQuarterly results for 31 March 2021
4th May 20215:40 pmRNSResult of AGM
28th Apr 20217:00 amRNSFunds advised by Apax Partners invest in Guesty
26th Mar 20213:05 pmRNSHolding(s) in Company
25th Mar 20217:00 amRNSFunds advised by Apax to acquire Rodenstock Group
19th Mar 20217:00 amRNSResult of secondary placing in Apax Global Alpha
18th Mar 20214:51 pmRNSSecondary placing of shares in Apax Global Alpha
17th Mar 20217:00 amRNSFunds advised by Apax to acquire Lutech
10th Mar 20212:03 pmRNSInitiation research from QuotedData
9th Mar 20215:40 pmRNSDirector/PDMR Shareholding
8th Mar 20217:00 amRNSInitial Public Offering of InnovAge
2nd Mar 20219:54 amRNS2020 Annual Dividend Declaration
2nd Mar 20217:00 amRNSKey Information Document
2nd Mar 20217:00 amRNSNotice of AGM
2nd Mar 20217:00 amRNS2020 Annual Dividend
2nd Mar 20217:00 amRNS2020 Annual Report and Accounts
2nd Mar 20217:00 amRNS2020 Final Results
15th Feb 202110:45 amRNSDirector Declaration
12th Feb 20217:00 amRNSFunds advised by Apax to acquire Herjavec Group
5th Feb 20217:00 amRNSApax Funds’ Valuations as at 31 December 2020
28th Jan 20217:00 amRNSApax Digital Fund sells stake in Signavio
26th Jan 20217:00 amRNSFunds Advised by Apax acquire PIB Group
19th Jan 202110:30 amRNSAmendment to Revolving Credit Facility
5th Jan 20217:00 amRNSThe Apax Funds sell minority stake in Paycor
29th Dec 20207:00 amRNSFunds Advised by Apax invest in Azentio Software
29th Dec 20207:00 amRNSFunds Advised by Apax Partners sell Boats Group
27th Nov 20204:42 pmRNSSecond Price Monitoring Extn
27th Nov 20204:36 pmRNSPrice Monitoring Extension
27th Nov 20201:43 pmRNSDirector/PDMR Shareholding
20th Nov 20207:00 amRNSFunds Advised by Apax Partners sell ECI
4th Nov 20207:00 amRNSQuarterly results for 30 September 2020
28th Oct 20207:00 amRNSGenius Sports Group SPAC
22nd Sep 20207:00 amRNSFunds advised by Apax Partners sell Neuraxpharm

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.